Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Presidio Partners, based in San Francisco, California, has over 25 years of experience in venture capital, previously operating as CMEA Capital. The firm specializes in venture investing and active portfolio management, adapting to market changes to enhance outcomes for their portfolio companies.
Presidio Partners invests in information technology, life sciences, and energy technology, targeting passionate teams and growing markets. Their strategy emphasizes company-building and innovative approaches to business models and pharmaceutical development, aiming for opportunities with global impact potential.
Notable investments include Exela Pharma Sciences, which focuses on securing U.S.-based drug supply and manufacturing; Solaria Corporation, engaged in advanced technology development; and Altimmune, which has made strides in developing a single-dose intranasal COVID-19 vaccine.
Presidio Partners focuses on sectors where they have deep expertise, including biotech, healthcare, and energy. They prioritize passionate teams and innovative business models that can adapt to market changes.
Yes, Presidio Partners often leads investment rounds, particularly in their areas of expertise, to help shape the direction of their portfolio companies.
The firm looks for companies in growing markets with global impact potential, particularly those in life sciences and energy technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.